http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 05 Jun 2025 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++VivoSim+Labs%2C+INC.++++++++For%3A+Mar+31/24904056.html si-local-file:///var/storage/secattach/20250605/24904056.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++VivoSim+Labs%2C+INC.++++++++For%3A+Mar+31/24904056.html Thu, 05 Jun 2025 16:06:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++VivoSim+Labs%2C+INC.++++++++For%3A+Mar+31/24904056.html si-local-file:///var/storage/secattach/20250605/24904056.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++VivoSim+Labs%2C+INC.++++++++For%3A+Mar+31/24904056.html Thu, 05 Jun 2025 16:06:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++VivoSim+Labs%2C+INC.+++++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/24806734.html si-local-file:///var/storage/secattach/20250515/24806734.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++VivoSim+Labs%2C+INC.+++++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/24806734.html Thu, 15 May 2025 15:36:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++VivoSim+Labs%2C+INC.+++++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/24806734.html si-local-file:///var/storage/secattach/20250515/24806734.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++VivoSim+Labs%2C+INC.+++++++++++++++++++++Filed+by%3A+ARMISTICE+CAPITAL%2C+LLC/24806734.html Thu, 15 May 2025 15:36:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+30/24746264.html si-local-file:///var/storage/secattach/20250506/24746264.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+30/24746264.html Tue, 06 May 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+30/24746264.html si-local-file:///var/storage/secattach/20250506/24746264.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+30/24746264.html Tue, 06 May 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+23/24679707.html si-local-file:///var/storage/secattach/20250424/24679707.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+23/24679707.html Thu, 24 Apr 2025 08:30:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+23/24679707.html si-local-file:///var/storage/secattach/20250424/24679707.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++VivoSim+Labs%2C+INC.++++++++For%3A+Apr+23/24679707.html Thu, 24 Apr 2025 08:30:00 -0400 O.11388205 ONVO http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Press+Releases/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html <p align="justify">SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.</p> <p align="justify">VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA’s push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim’s market adoption, disrupting a &gt;$10B animal testing http://www.streetinsider.com/Globe+Newswire/VivoSim+Announces+Emergence+from+Stealth+Mode+To+Provide+Technologies%C2%A0for+FDA+Turn+Away+from+Animal+Models%2C+%2410B%2B+Market/24679500.html Thu, 24 Apr 2025 08:05:00 -0400 O.11388205 ONVO VIVS http://www.streetinsider.com/Corporate+News/Organovo+%28ONVO%29+Rebrands+as+VivoSim+Labs+%28VIVS%29/24672215.html <p>Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p><p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p><p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol change. The Company’s common stock will continue to be listed on the Nasdaq Capital Market and the CUSIP number http://www.streetinsider.com/Corporate+News/Organovo+%28ONVO%29+Rebrands+as+VivoSim+Labs+%28VIVS%29/24672215.html Wed, 23 Apr 2025 08:06:09 -0400 ONVO VIVS http://www.streetinsider.com/Corporate+News/Organovo+%28ONVO%29+Rebrands+as+VivoSim+Labs+%28VIVS%29/24672215.html <p>Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p><p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p><p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol change. The Company’s common stock will continue to be listed on the Nasdaq Capital Market and the CUSIP number http://www.streetinsider.com/Corporate+News/Organovo+%28ONVO%29+Rebrands+as+VivoSim+Labs+%28VIVS%29/24672215.html Wed, 23 Apr 2025 08:06:09 -0400 ONVO VIVS http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+23/24672219.html si-local-file:///var/storage/secattach/20250423/24672219.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+23/24672219.html Wed, 23 Apr 2025 08:06:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+23/24672219.html si-local-file:///var/storage/secattach/20250423/24672219.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+23/24672219.html Wed, 23 Apr 2025 08:06:00 -0400 O.11388205 ONVO http://www.streetinsider.com/Press+Releases/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html <p align="justify">SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p> <p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p> <p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol http://www.streetinsider.com/Press+Releases/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html Wed, 23 Apr 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/Press+Releases/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html <p align="justify">SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p> <p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p> <p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol http://www.streetinsider.com/Press+Releases/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html Wed, 23 Apr 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/Globe+Newswire/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html <p align="justify">SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p> <p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p> <p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol http://www.streetinsider.com/Globe+Newswire/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html Wed, 23 Apr 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/Globe+Newswire/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html <p align="justify">SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.</p> <p align="justify">A name change of the Company to VivoSim Labs, Inc. will be effective on April 24, 2025, and the Company’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “VIVS” at market open on April 24, 2025.</p> <p align="justify">No action is required by existing stockholders with respect to the name and ticker symbol http://www.streetinsider.com/Globe+Newswire/VivoSim+to+Carry+Forward+Organovo+3D+Bioprinting/24672206.html Wed, 23 Apr 2025 08:05:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ORGANOVO+HOLDINGS%2C+INC.++++++++++++++/24629103.html si-local-file:///var/storage/secattach/20250411/24629103.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ORGANOVO+HOLDINGS%2C+INC.++++++++++++++/24629103.html Fri, 11 Apr 2025 09:16:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ORGANOVO+HOLDINGS%2C+INC.++++++++++++++/24629103.html si-local-file:///var/storage/secattach/20250411/24629103.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ORGANOVO+HOLDINGS%2C+INC.++++++++++++++/24629103.html Fri, 11 Apr 2025 09:16:00 -0400 O.11388205 ONVO http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+02/24587095.html si-local-file:///var/storage/secattach/20250402/24587095.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORGANOVO+HOLDINGS%2C+INC.+++For%3A+Apr+02/24587095.html Wed, 02 Apr 2025 08:06:00 -0400 O.11388205 ONVO